investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

A Novel Biomarker Discovery Strategy Combining Primary Tumour Xenograft Models and Glyco-Capture of Secreted Proteins

Thomas Kislinger

0 Collaborator(s)

Funding source

Canadian Institutes of Health Research (CIHR)

Related projects

Mary Anne Rossing

Epidemiologic Factors and Survival by Molecular Subtypes of Ovarian Cancer

Ovary

Pathology

Igor Jurisica

CRC Tier 1 - Tools and resources for systematically discovering clinically-relevant biomarkers of cancer

Ovary

Susan J Ramus

Identifying Prognostic Markers and Therapeutic Targets for Serous Ovarian Cancer

Ovary

Pathology

Janet E Dancey

NCIC Clinical Trials Group - Canadian Collaborating Clinical Trials Network

Ovary

Linda S Cook

Mitochondrial DNA and Ovarian Cancer Risk and Survival

Ovary

Pathology

Eleftherios P Diamandis

An Integrated Systems Biology Approach for Ovarian Cancer Biomarker Discovery

Ovary

Pathology

Theodore Brown

Sustained ovulation-associated inflammatory signaling in fallopian tube epithelium as a predisposing factor of serous carcinoma

Ovary

Sohrab Shah

Genomic Disruption in High-Grade Serous Ovarian Carcinomas: Steady State or Continuous Drift?

Ovary

Charles D Blanke

SWOG Network Group Operations Center of the NCTN

Ovary